Jeffrey L. Cummings pictured in a white lab coat in his lab on UNLV's campus

Study Finds Nonprofits, Federal Government Surpass Pharma to Lead Alzheimer's Drug Development

UNLV research professor Jeffrey L. Cummings examines Alzheimer's clinical trials pipeline in two new studies.

A new study by UNLV research professor Jeffrey L. Cummings finds that federal agencies and nonprofits have overtaken pharma as the primary drivers of growth and innovation for Alzheimer's disease drug development. (Lonnie Timmons III/UNLV Photo Services)

  • Research
  • June 7, 2021
  • By UNLV News Center
  • Andrea Roa, UNLV School of Integrated Health Sciences, (702) 895-3269;

You Might Also Like